Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 9/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 8/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9571369 | 0.83 | CA2 (0.54) | CA2PTGS1PTGS2CA1SLC22A12 | |
| SCHEMBL5776943 | 0.82 | CXCL8 (0.53) | CA2PTGS1PTGS2 | |
| SCHEMBL11122074 | 0.81 | CA2 (0.49) | CA2PTGS1PTGS2MAPK1SMN1; SMN2 | |
| SCHEMBL26622091 | 0.79 | CA2 (0.47) | CA2PTGS1PTGS2CA1SLC22A12 | |
| SCHEMBL5778304 | 0.79 | PTGS1 (0.47) | CA2PTGS1PTGS2SLC22A12MAPK1 | |
| SCHEMBL12054691 | 0.78 | CA2 (0.66) | CA2PTGS1PTGS2CA1MAPK1 | |
| SCHEMBL11125379 | 0.77 | PTGS1 (0.46) | CA2PTGS1PTGS2ALDH1A1SLC22A12 | |
| SCHEMBL4963565 | 0.77 | KEAP1 (0.55) | PTGS1ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL5879757 | 0.75 | PTGES2 (0.60) | ALDH1A1 | |
| SCHEMBL9329237 | 0.75 | SLC16A3 (0.48) | ALDH1A1HPGDSLC22A12SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025089147-A1 | HERBICIDAL COMPOSITION | 株式会社エス・ディー・エス バイオテック | 2025-05-01 | — | — | WO | disclosed |
| WO-2023210623-A1 | HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME | 株式会社エス・ディー・エス バイオテック | 2023-11-02 | — | — | WO | disclosed |
| CN-102137841-B | Ortho-substituted haloalkylsulfonanilide derivative and herbicide | NISSAN CHEMICAL IND LTD | 2014-05-14 | — | — | CN | disclosed |
| EP-2420493-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | Nissan Chemical Industries, Ltd. (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
| CN-102137841-A | Ortho-substituted haloalkylsulfonanilide derivative and herbicide | NISSAN CHEMICAL IND LTD | 2011-07-27 | — | — | CN | disclosed |
| EP-2336104-A1 | ORTHO-SUBSTITUTED HALOALKYLSULFONANILIDE DERIVATIVE AND HERBICIDE | Nissan Chemical Industries, Ltd. (JP) | 2011-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | CBR3, CBR1, HDHD5 | CA2 200/4885PTGS1 3479/4885PTGS2 4244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.